Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Pietro Sollena"'
Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR Inhibitors
Autor:
Eleonora De Luca, Pietro Sollena, Lucia Di Nardo, Ettore D’Argento, Emanuele Vita, Giampaolo Tortora, Ketty Peris
Publikováno v:
Dermatology Research and Practice, Vol 2024 (2024)
Papulopustular rash (PPR) is the most frequent cutaneous adverse event during treatment with epidermal growth factor receptor inhibitors (EGFRis). Although often mild in severity, it can impair patients’ quality of life and may also be a reason for
Externí odkaz:
https://doaj.org/article/b8cab60b1e60421f9c2e73ca03bd6e18
Autor:
Martina Merli, Martina Accorinti, Maurizio Romagnuolo, Angelo Marzano, Giovanni Di Zenzo, Francesco Moro, Emiliano Antiga, Roberto Maglie, Emanuele Cozzani, Aurora Parodi, Giulia Gasparini, Pietro Sollena, Clara De Simone, Marzia Caproni, Luigi Pisano, Davide Fattore, Riccardo Balestri, Paolo Sena, Pamela Vezzoli, Miriam Teoli, Marco Ardigò, Camilla Vassallo, Andrea Michelerio, Rosanna Rita Satta, Emi Dika, Barbara Melotti, Simone Ribero, Pietro Quaglino
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Cutaneous immune-related adverse events are frequently associated with immune checkpoint inhibitors (ICIs) administration in cancer patients. In fact, these monoclonal antibodies bind the cytotoxic T-lymphocyte antigen-4 and programmed cell death-1/l
Externí odkaz:
https://doaj.org/article/54cab3571bda4d5c925013a4dc3c5c86
Autor:
Mariangela Pasqualoni, Armando Orlandi, Antonella Palazzo, Giovanna Garufi, Maria Chiara Cannizzaro, Letizia Pontolillo, Sergio Pannunzio, Claudia Cutigni, Pietro Sollena, Francesco Federico, Emilio Bria, Giampaolo Tortora
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Cancer treatment-related adverse events (AEs) are sometimes associated with outcomes for cancer patients, especially with the newest therapies such as target therapy and immunotherapy. A few years ago, the first-line therapy for hormone-receptor-posi
Externí odkaz:
https://doaj.org/article/3c48f71fdec24fac8a1c8c87b11344a2
Autor:
Pietro Sollena, Simone Cappilli, Francesco Federico, Giovanni Schinzari, Giampaolo Tortora, Ketty Peris
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 3 (2022)
Immune checkpoint inhibitors have shown efficacy in the treatment of different cancers by stimulating the antitumoral activity of the patient’s immune system, representing a major breakthrough in the field of cancer therapy. Monoclonal antibodies i
Externí odkaz:
https://doaj.org/article/8ce116d87df643c8864405b50ad086c1
Publikováno v:
International Journal of Infectious Diseases, Vol 97, Iss , Pp 23-26 (2020)
Economical and psychological consequences of the lockdown in low-resource setting in rural Africa are unknown. We drafted a survey in order to address the social impact of COVID-19 lockdown on a rural village in Sierra Leone. The survey developed by
Externí odkaz:
https://doaj.org/article/218d20920bef41ec9fb0848d19ccd4f6
Autor:
Pietro Sollena, Maria Mannino, Francesco Tassone, Maria Alessandra Calegari, Ettore D’Argento, Ketty Peris
Publikováno v:
Drugs in Context, Vol 8, Pp 1-7 (2019)
Nail toxicities, such as paronychia and pyogenic granuloma-like lesions, are well-recognized side effects of epidermal growth factor receptor inhibitor (EGFR-I) therapy that can significantly impair patient’s quality of life and compliance to antic
Externí odkaz:
https://doaj.org/article/21410e37528d4520835dc21947b6cb7a
Autor:
Vasiliki A. Nikolaou, Zoe Apalla, Cristina Carrera, Davide Fattore, Pietro Sollena, Julia Riganti, Sonia Segura, Azael Freites-Martinez, Konstantinos Lallas, Maria Concetta Romano, Chrysa Oikonomou, Michela Starace, Meletios A. Dimopoulos, Athanassios Kyrgidis, Elizabeth Lazaridou, Priscila Giavedoni, Maria Carmela Annunziata, Ketty Peris, Maria Echeverría, Emilio Lopez-Tujillo, Konstandinos Syrigos, Chryssoula Papageorgiou, Sebastian Podlipnik, Gabriella Fabbrocini, Ana C. Torre, Christina Kemanetzi, Lorena Villa-Crespo, Aimilios Lallas, Alexander J. Stratigos, Vincent Sibaud
Publikováno v:
British Journal of Dermatology. 187:962-969
Summary Background Cutaneous immune-related adverse events (irAEs) represent the most frequent toxicities induced by immune checkpoint inhibitors (ICIs). Objectives To investigate clinical associations of cutaneous toxicities induced by different ICI
Autor:
Azael Freites-Martinez, Vasiliki Nikolaou, Konstantinos Lallas, Cristina Carrera, Pietro Sollena, Zoe Apalla, Michela Starace, Davide Fattore, Gabriella Fabbrocini, Sonia Segura, Julia Riganti, Vincent Sibaud
Publikováno v:
Journal of the American Academy of Dermatology. 88:718-720
Publikováno v:
Italian Journal of Dermatology and Venereology.
Autor:
Maria, Mannino, Pietro, Sollena, Maria, Esposito, Fargnoli, MARIA CONCETTA, Ketty, Peris, Eduardo, Nagore
Publikováno v:
Dermatology (Basel, Switzerland). 238(5)
Cutaneous melanoma accounts for the majority of skin cancer-related deaths. Readily identifiable phenotypic characteristics and total body nevus count (TBNC)50 are among the most important risk factors for cutaneous melanoma. Implementation of nevus